U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639177) titled 'Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis' on June 05.
Brief Summary: In this 24-week, single center, randomized, double-blind, placebo-controlled study, the efficacy and safety of lyophilised oral fecal microbiota transplantation in patients with active refractory rheumatoid arthritis will be evaluated.
Study Start Date: June 15
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis
Intervention:
DRUG: lyophilised oral capsules with faecal microbiota
Faecal microbiota is extracted from fresh stool collected from strictly screened health donors with canonical procedure, and then ly...